Search

Laboratorios Farmaceuticos Rovi SA

Închisă

SectorSănătate

60.05 -0.74

Rezumat

Modificarea prețului

24h

Curent

Minim

60.2

Maxim

60.7

Indicatori cheie

By Trading Economics

Venit

80M

89M

Vânzări

39M

192M

P/E

Medie Sector

16.616

57.366

EPS

1.466

Randament dividend

1.6

Marjă de profit

46.582

Angajați

2,470

EBITDA

83M

101M

Dividende

By Acuity

Randament dividend

Medie Sector

1.60%

2.16%

Următoarele câștiguri

5 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

302M

3.1B

Deschiderea anterioară

60.79

Închiderea anterioară

60.05

Sentimentul știrilor

By Acuity

59%

41%

297 / 340 Clasament în Healthcare

Laboratorios Farmaceuticos Rovi SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 aug. 2026, 23:56 UTC

News

Array Technologies has acquired Affordable Wire Management, enhancing its portfolio and growth potential. Shares are trading slightly higher in after-market hours.

31 aug. 2026, 23:56 UTC

News

Frontier Group Holdings plans to terminate leases for 13 A320neo aircraft, leading to anticipated charges of $60 million to $80 million. Shares are lower in after-market hours.

31 aug. 2026, 23:51 UTC

News

Howmet Aerospace shares are higher in after-market hours following Elon Musk's comments on SpaceX's gas turbine blade plans, sparking renewed interest and improved sentiment.

31 aug. 2026, 23:46 UTC

News

American Water Works shares are trading higher in after-market hours amid a pending merger settlement approval from the Pennsylvania Public Utility Commission.

31 aug. 2026, 23:46 UTC

Correlated Moves
News

Renasant Corp appointed Catherine Mealor as Executive Vice President, effective October 2026. Shares are trading higher in after-market hours following the announcement.

31 aug. 2026, 23:46 UTC

News

IQVIA Holdings Inc shares are higher in after-market trading, remaining above their 20-day moving average amid sector growth expectations despite ongoing challenges.

31 aug. 2026, 23:41 UTC

News

Quantum Corp shares declined in after-market trading amid broader market sentiment affected by hawkish comments from Federal Reserve Chair Kevin Warsh on inflation.

31 aug. 2026, 23:41 UTC

Event
News

Jazz Pharmaceuticals PLC reported positive results from the HERIZON-GEA-01 trial for Ziihera, leading shares higher in after-hours trading.

31 aug. 2026, 23:41 UTC

News

KeyCorp shares are higher in after-market hours following the appointment of Chris Doll as Chief Strategy Officer, effective August 31, 2026.

31 aug. 2026, 23:16 UTC

News

Delek US Holdings Inc. supports Small Refinery Exemptions, enabling increased investments in refineries and U.S. energy infrastructure. Shares are higher in after-market trading.

31 aug. 2026, 23:16 UTC

News

Sylvamo Corp shares are higher in after-market hours, buoyed by strong institutional ownership and earnings per share of $1.88.

31 aug. 2026, 23:11 UTC

Social Media
News

Coinbase Global shares are lower in after-market trading, amid ongoing interest and developments in the crypto space, including Webull's new services in Canada.

31 aug. 2026, 23:11 UTC

News

Under Armour has filed for a mixed shelf offering, including potential debt and equity. Shares traded roughly flat during after-market hours.

31 aug. 2026, 23:11 UTC

News

Northrop Grumman secured an $86.1 million contract extension from the U.S. Department of War, boosting shares higher in after-market trading.

31 aug. 2026, 23:11 UTC

Correlated Moves
News

The USD/PLN is lower today, influenced by comments from Federal Reserve Chair Kevin Warsh regarding potential interest rate hikes amid rising inflation concerns.

31 aug. 2026, 23:06 UTC

News

Oracle Corp is higher in after-market trading, despite challenges including a record low free cash flow yield and concerns about its hyperscaler strategy.

31 aug. 2026, 23:06 UTC

News

Ares Capital Corp raised ¥612 billion for its Japan Logistics Development Partners V LP, exceeding its predecessor's size. Shares are higher in after-market hours.

31 aug. 2026, 23:06 UTC

Social Media
News

KKR & Co Inc. shares are higher in after-market hours following the firm's support for Wella Co's upcoming IPO on the New York Stock Exchange.

31 aug. 2026, 23:06 UTC

News

RTX Corp partners with Lockheed Martin and Tata Advanced Systems for Javelin missile co-production in India. Shares are higher in after-market trading.

31 aug. 2026, 23:06 UTC

Event
News

Eli Lilly shares are higher in after-market trading following regulatory clearance for its merger with AtaiBeckley, marking a key milestone in the process.

31 aug. 2026, 23:06 UTC

News

Johnson & Johnson shares are higher in after-market trading following the announcement of an investor conference call on October 13, 2026, for third-quarter results.

31 aug. 2026, 23:06 UTC

Correlated Moves
News

The USD/NOK is trading lower, reflecting a decline since Friday. Market sentiment shifts after comments from Federal Reserve Chair Kevin Warsh on inflation and interest rates.

31 aug. 2026, 23:06 UTC

News
Correlated Moves

Geopolitical tensions and hawkish Fed remarks are supporting gains in CAD/HKD, which is trading near the upper end of its one-month range.

31 aug. 2026, 23:06 UTC

Correlated Moves
News

The USD/SGD is lower today, influenced by Federal Reserve comments on inflation and rising Treasury yields. The pair remains near its one-month range's lower end.

31 aug. 2026, 23:01 UTC

News

Global Water Resources Inc shares lower after announcing a $0.03 dividend, with analysts projecting earnings of $0.13 per share next year.

31 aug. 2026, 23:01 UTC

News

Align Technology shares are lower in after-market trading following the appointment of Quentin Blackford to its Board of Directors, effective immediately.

31 aug. 2026, 23:01 UTC

News

elf Beauty Inc shares are lower in after-market trading amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh.

31 aug. 2026, 23:01 UTC

News

Charter Communications shares are lower in after-market hours following the announcement of CFO Jessica Fischer's resignation effective October 15, 2026.

31 aug. 2026, 23:01 UTC

News

Avista Corp seeks to reduce natural gas rates by about 11.5%, potentially lowering bills by $7.38. Shares advanced in after-market trading.

31 aug. 2026, 23:01 UTC

Social Media
News

Evercore upgraded Duolingo to Outperform, raising its price target to $210. Shares rose after market close, reflecting positive sentiment around the stock.

Comparație

Modificare preț

Laboratorios Farmaceuticos Rovi SA Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

0

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

297 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
help-icon Live chat